What causes high apolipoprotein B?

High apolipoprotein B (ApoB) levels are primarily caused by diet high in saturated fats, genetics, metabolic conditions like diabetes and insulin resistance, and lifestyle factors. ApoB is a better predictor of heart disease risk than traditional cholesterol tests since each atherogenic particle contains one ApoB molecule.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Apolipoprotein B and Its Role in Heart Health

Apolipoprotein B (ApoB) is a protein that acts as the structural backbone of several lipoproteins that carry cholesterol and fats through your bloodstream. Unlike traditional cholesterol tests that measure the cholesterol content within particles, ApoB counts the actual number of atherogenic (artery-clogging) particles in your blood. Each potentially harmful lipoprotein particle - including LDL, VLDL, IDL, and Lp(a) - contains exactly one ApoB molecule, making it a more accurate predictor of cardiovascular disease risk than LDL cholesterol alone.

Research shows that ApoB is superior to LDL cholesterol for predicting heart attack and stroke risk. This is because two people can have identical LDL cholesterol levels but vastly different numbers of LDL particles. The person with more particles (higher ApoB) faces greater cardiovascular risk, as each particle can potentially penetrate and damage arterial walls. Understanding what drives ApoB levels higher is crucial for preventing heart disease.

Primary Dietary Causes of Elevated ApoB

Your diet plays a fundamental role in determining ApoB levels. The most significant dietary contributors to high ApoB include:

Saturated and Trans Fats

Saturated fats, found in red meat, full-fat dairy products, coconut oil, and palm oil, stimulate the liver to produce more ApoB-containing particles. Trans fats, though largely eliminated from the food supply, are even more harmful when consumed. These fats not only increase ApoB production but also reduce the liver's ability to clear these particles from circulation. Studies show that replacing just 5% of calories from saturated fat with unsaturated fats can reduce ApoB levels by 5-10%.

Refined Carbohydrates and Added Sugars

High intake of refined carbohydrates and added sugars triggers increased production of VLDL particles in the liver, each containing one ApoB molecule. When you consume excess sugar, particularly fructose, your liver converts it to fat through a process called de novo lipogenesis. This newly created fat is packaged into VLDL particles for transport, directly increasing your ApoB count. Regular consumption of sugar-sweetened beverages has been particularly linked to elevated ApoB levels.

Dietary Cholesterol Impact

While dietary cholesterol's effect on blood cholesterol has been debated, recent research suggests that in about 25% of the population (termed 'hyper-responders'), dietary cholesterol can significantly increase ApoB levels. Foods high in cholesterol, such as egg yolks and organ meats, may need to be limited in these individuals. If you're concerned about your cardiovascular risk factors, comprehensive testing can help identify whether you're sensitive to dietary cholesterol.

Genetic and Inherited Factors

Genetics play a substantial role in determining baseline ApoB levels and how your body processes lipoproteins. Several genetic conditions can cause elevated ApoB:

Familial Hypercholesterolemia (FH)

This inherited disorder affects approximately 1 in 250 people and causes extremely high levels of LDL particles and ApoB from birth. People with FH have mutations in genes responsible for clearing LDL particles from the blood, particularly the LDL receptor gene. Without treatment, individuals with FH can have ApoB levels two to three times higher than normal, leading to premature heart disease.

Familial Combined Hyperlipidemia (FCH)

FCH is the most common inherited lipid disorder, affecting 1-2% of the population. It causes overproduction of VLDL particles in the liver, leading to elevated ApoB levels. People with FCH often have a characteristic pattern of high triglycerides, high ApoB, and normal or slightly elevated LDL cholesterol. This condition significantly increases cardiovascular risk and often runs in families with early heart disease.

ApoB Gene Variants

Variations in the APOB gene itself can affect how much ApoB your body produces and how efficiently it's cleared. Some genetic variants lead to increased production of ApoB-containing particles, while others affect the structure of ApoB, making the particles more likely to stick to artery walls. These genetic factors can explain why some people have high ApoB despite following a healthy diet.

Metabolic Conditions That Raise ApoB

Several metabolic conditions can significantly impact ApoB levels by affecting how your body produces and clears lipoproteins:

Insulin Resistance and Type 2 Diabetes

Insulin resistance is one of the strongest drivers of elevated ApoB levels. When cells become resistant to insulin, the liver increases production of VLDL particles, each containing ApoB. Additionally, insulin resistance impairs the normal breakdown of triglyceride-rich particles, causing them to remain in circulation longer. People with Type 2 diabetes often have ApoB levels 20-30% higher than those with normal insulin sensitivity, even when LDL cholesterol appears normal.

Metabolic Syndrome

Metabolic syndrome, characterized by abdominal obesity, high blood pressure, elevated blood sugar, and abnormal lipid levels, strongly correlates with high ApoB. The combination of insulin resistance, inflammation, and altered fat metabolism in metabolic syndrome creates a perfect storm for ApoB elevation. Studies show that each component of metabolic syndrome independently contributes to higher ApoB levels.

Hypothyroidism

An underactive thyroid significantly impacts lipid metabolism. Thyroid hormones play a crucial role in regulating the LDL receptors that clear ApoB-containing particles from the blood. When thyroid hormone levels are low, these receptors decrease in number and activity, causing ApoB levels to rise. Even subclinical hypothyroidism (slightly elevated TSH with normal thyroid hormones) can increase ApoB by 10-20%. Regular monitoring of both thyroid function and cardiovascular markers is essential for optimal health.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Lifestyle Factors Contributing to High ApoB

Beyond diet, several lifestyle factors can significantly impact your ApoB levels:

  • Physical Inactivity: Sedentary behavior reduces the muscles' ability to clear triglyceride-rich particles and decreases LDL receptor activity. Regular exercise can lower ApoB by 5-15%.
  • Excess Alcohol Consumption: While moderate alcohol intake may have neutral effects, excessive drinking stimulates the liver to produce more VLDL particles, raising ApoB levels.
  • Smoking: Cigarette smoking oxidizes ApoB-containing particles, making them more atherogenic and reducing the liver's ability to clear them from circulation.
  • Chronic Stress: Prolonged stress elevates cortisol levels, which can increase liver production of VLDL and raise ApoB. Stress also often leads to poor dietary choices that further elevate levels.
  • Poor Sleep Quality: Sleep deprivation and sleep apnea are associated with insulin resistance and altered lipid metabolism, both contributing to higher ApoB levels.

Medications and Medical Conditions

Certain medications can raise ApoB levels as a side effect. These include some diuretics, beta-blockers, corticosteroids, and immunosuppressants. Additionally, medical conditions affecting the liver or kidneys can impair the body's ability to clear ApoB-containing particles:

  • Chronic Kidney Disease: Reduced kidney function impairs the clearance of ApoB-containing particles and alters their composition, making them more atherogenic.
  • Liver Disease: Since the liver produces and clears most ApoB-containing particles, liver dysfunction can lead to abnormal ApoB levels.
  • Cushing's Syndrome: Excess cortisol production increases VLDL synthesis and can significantly elevate ApoB.
  • Pregnancy: ApoB levels naturally rise during pregnancy to support fetal development but should return to normal postpartum.

Age and Gender Influences

ApoB levels naturally change throughout life and differ between men and women. In men, ApoB typically rises gradually from puberty through middle age, plateauing around age 50-60. Women generally have lower ApoB levels than men until menopause, when the protective effects of estrogen diminish. Post-menopausal women often experience a sharp increase in ApoB levels, sometimes surpassing those of men the same age.

The loss of estrogen during menopause affects multiple aspects of lipid metabolism, including reduced LDL receptor activity and increased VLDL production. This explains why cardiovascular disease risk in women increases dramatically after menopause and highlights the importance of monitoring ApoB levels during this transition.

Testing and Monitoring Your ApoB Levels

Given ApoB's superior predictive value for cardiovascular disease, regular testing is crucial, especially if you have risk factors. Optimal ApoB levels are generally considered to be:

  • Below 90 mg/dL for most adults
  • Below 80 mg/dL for those with diabetes or metabolic syndrome
  • Below 70 mg/dL for those with established cardiovascular disease
  • Below 60 mg/dL for those with very high risk or recurrent events

Unlike basic cholesterol panels, ApoB testing provides a complete picture of your atherogenic particle burden. Many people with 'normal' LDL cholesterol have elevated ApoB, putting them at hidden risk. This discordance is particularly common in people with metabolic syndrome, diabetes, or high triglycerides.

If you're interested in understanding your complete cardiovascular risk profile beyond standard cholesterol tests, consider getting your ApoB levels checked along with other advanced markers. For a free analysis of your existing blood test results, you can use SiPhox Health's blood test upload service to get personalized insights and recommendations based on your current biomarkers.

Natural Strategies to Lower ApoB

Fortunately, many of the factors that raise ApoB are modifiable through lifestyle changes:

  • Adopt a Mediterranean-style diet rich in olive oil, nuts, fish, and vegetables
  • Replace saturated fats with monounsaturated and polyunsaturated fats
  • Increase soluble fiber intake from oats, beans, and psyllium
  • Limit added sugars to less than 25 grams per day
  • Engage in at least 150 minutes of moderate-intensity exercise weekly
  • Maintain a healthy weight, particularly reducing abdominal fat
  • Manage stress through meditation, yoga, or other relaxation techniques
  • Prioritize 7-9 hours of quality sleep nightly
  • Consider plant sterols and stanols, which can lower ApoB by 5-10%

Taking Control of Your Cardiovascular Health

High apolipoprotein B levels result from a complex interplay of dietary choices, genetic factors, metabolic conditions, and lifestyle habits. While you can't change your genetics, you have significant control over many factors that influence ApoB. Understanding these causes empowers you to make targeted changes that can substantially reduce your cardiovascular disease risk.

Remember that ApoB is a superior marker to traditional cholesterol tests for predicting heart disease risk. If you have risk factors like family history, metabolic syndrome, or simply want to optimize your health, regular ApoB testing can provide valuable insights that standard panels miss. By addressing the root causes of elevated ApoB through diet, exercise, and when necessary, medical treatment, you can significantly improve your long-term cardiovascular health outcomes.

References

  1. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295.[Link][PubMed][DOI]
  2. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal. 2017;38(32):2459-2472.[Link][PubMed][DOI]
  3. Langlois MR, Chapman MJ, Cobbaert C, et al. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM. Clin Chem. 2018;64(7):1006-1033.[Link][PubMed][DOI]
  4. Behbodikhah J, Ahmed S, Elyasi A, et al. Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target. Metabolites. 2021;11(10):690.[Link][PubMed][DOI]
  5. Glavinovic T, Thanassoulis G, de Graaf J, et al. Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. J Am Heart Assoc. 2022;11(20):e025858.[Link][PubMed][DOI]
  6. Richardson TG, Sanderson E, Palmer TM, et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. PLoS Med. 2020;17(3):e1003062.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my apolipoprotein B at home?

You can test your apolipoprotein B at home with SiPhox Health's Apob Advanced Cholesterol Panel, which includes ApoB testing along with other crucial cardiovascular markers. The test provides lab-quality results from the comfort of your home.

What is the difference between ApoB and LDL cholesterol?

LDL cholesterol measures the cholesterol content within LDL particles, while ApoB counts the actual number of all atherogenic particles (LDL, VLDL, IDL, and Lp(a)). Since each harmful particle contains exactly one ApoB molecule, ApoB provides a more accurate assessment of cardiovascular risk than LDL cholesterol alone.

Can you have normal LDL but high ApoB?

Yes, this discordance is common, especially in people with metabolic syndrome, diabetes, or high triglycerides. You might have many small, dense LDL particles that don't carry much cholesterol (normal LDL-C) but still represent high cardiovascular risk (high ApoB). This is why ApoB testing is important even if your standard cholesterol looks normal.

How quickly can lifestyle changes lower ApoB levels?

Dietary changes can begin affecting ApoB levels within 2-4 weeks, with more significant reductions seen after 6-12 weeks. Exercise effects may take 8-12 weeks to fully manifest. The magnitude of change depends on baseline levels and the intensity of lifestyle modifications, with combined diet and exercise typically reducing ApoB by 10-25%.

What foods most effectively lower ApoB?

Foods rich in soluble fiber (oats, beans, apples), omega-3 fatty acids (fatty fish, walnuts), and monounsaturated fats (olive oil, avocados) are most effective. Plant sterols and stanols found in fortified foods can also help. Replacing saturated fats with these foods while limiting added sugars provides the greatest ApoB reduction.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details